Prelude Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-11,992
| Closed | -$78.2K | – | 1308 |
|
|
2024
Q2 | $78.2K | Sell |
11,992
-10,407
| -46% | -$67.9K | 0.01% | 1029 |
|
|
2024
Q1 | $195K | Buy |
+22,399
| New | +$195K | 0.01% | 1011 |
|
|
2022
Q4 | – | Sell |
-53,485
| Closed | -$554K | – | 1316 |
|
|
2022
Q3 | $554K | Buy |
53,485
+449
| +0.8% | +$4.65K | 0.02% | 600 |
|
|
2022
Q2 | $612K | Sell |
53,036
-14,246
| -21% | -$164K | 0.02% | 591 |
|
|
2022
Q1 | $846K | Hold |
67,282
| – | – | 0.02% | 513 |
|
|
2021
Q4 | $785K | Sell |
67,282
-1,571
| -2% | -$18.3K | 0.02% | 562 |
|
|
2021
Q3 | $899K | Sell |
68,853
-59,014
| -46% | -$771K | 0.02% | 445 |
|
|
2021
Q2 | $1.65M | Sell |
127,867
-12,471
| -9% | -$161K | 0.05% | 277 |
|
|
2021
Q1 | $1.57M | Buy |
+140,338
| New | +$1.57M | 0.04% | 236 |
|
|
2019
Q2 | – | Sell |
-636
| Closed | -$7K | – | 1467 |
|
|
2019
Q1 | $7K | Buy |
+636
| New | +$7K | ﹤0.01% | 1201 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1444 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1376 |
|
|
2017
Q3 | – | Sell |
-35,701
| Closed | -$565K | – | 1625 |
|
|
2017
Q2 | $565K | Sell |
35,701
-6,014
| -14% | -$95.2K | 0.05% | 273 |
|
|
2017
Q1 | $596K | Buy |
41,715
+14,247
| +52% | +$204K | 0.06% | 282 |
|
|
2016
Q4 | $352K | Sell |
27,468
-27,167
| -50% | -$348K | 0.04% | 360 |
|
|
2016
Q3 | $727K | Buy |
+54,635
| New | +$727K | 0.08% | 229 |
|